Evidence map›Paper›PMID 31440633›Full record

ArticleSpine surgery and related research2017

Indications for prophylactic lumbar decompression at the L3/4 level in patients with L4/5 responsible lumbar spinal canal stenosis.

Toru Asari, Shuichi Aburakawa, Gentaro Kumagai, Sunao Tanaka, Yasuyuki Ishibashi

Abstract read
In one paragraph

Article in Spine surgery and related research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Toru AsariDepartment of Orthopedic Surgery, Aomori Rosai Hospital, Hachinohe, Aomori, Japan.
Shuichi AburakawaDepartment of Orthopedic Surgery, Aomori Rosai Hospital, Hachinohe, Aomori, Japan.
Gentaro KumagaiDepartment of Orthopedic Surgery, Aomori Rosai Hospital, Hachinohe, Aomori, Japan.
Sunao TanakaDepartment of Orthopedic Surgery, Aomori Rosai Hospital, Hachinohe, Aomori, Japan.
Yasuyuki IshibashiDepartment of Orthopedic Surgery, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLumbar spinal canal stenosis (LSS) is a very common disease. When the responsible level is considered to be L4/5 despite the appearance of double-level (L3/4 and L4/5) stenosis on magnetic resonance imaging (MRI), it is difficult for spinal surgeons to decide whether prophylactic decompression should be performed at the L3/4 level. The purpose of this study was to investigate the relationship between the dural sac cross-sectional area (DCSA) at the L3/4 level and clinical symptoms in patients with double-level stenosis.

methodsThirty-five patients with double-level stenosis were registered in this study. All patients underwent decompression surgery at the L4/5 responsible level. The severity of patients' symptoms was evaluated by the Japanese Orthopaedic Association (JOA) score and its rate of recovery. A measurement program on MRI was used to determine the DCSA.

resultsThe clinical course of LSS according to the JOA score recovery rate at the final follow-up revealed that the good group (≥50%) included 27 patients, and the poor group (<50%) included 8 patients. In the good group, the mean DCSA at the L3/4 level was 72.3 ± 32.1 mm

conclusionsConsidering the present results, prophylactic decompression surgery at the L3/4 level should be performed for patients with double-level stenosis and DCSA <50 mm

Indexed as

double-level stenosisdural sac cross-sectional areaJapanese Orthopaedic Association scorelumbar spinal canal stenosisprophylactic decompression surgery

Identifiers

PMID31440633
PMCPMC6698573

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.